Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections
Abstract Guaifenesin, a mucoactive drug, acts by loosening mucus in the airways and making coughs more productive. It is used for relief of wet cough and chest congestion due to the common cold, and remains the only legally marketed expectorant in the US (per OTC Monograph). An ingredient in numerou...
Main Authors: | Helmut H. Albrecht, Peter V. Dicpinigaitis, Eric P. Guenin |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2017-12-01
|
Series: | Multidisciplinary Respiratory Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40248-017-0113-4 |
Similar Items
-
Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms
by: Albrecht Helmut, et al.
Published: (2012-12-01) -
Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection
by: Tripathi S, et al.
Published: (2019-10-01) -
A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis
by: Mayer Falcon, et al.
Published: (2019-03-01) -
Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study
by: Edward J. Septimus, MD, FIDSA, FACP, FSHEA, et al.
Published: (2017-01-01) -
Effects of guaifenesin, <it>N</it>-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells
by: Seagrave JeanClare, et al.
Published: (2012-10-01)